VANGUARD GROUP INC - PLX PHARMA INC ownership

PLX PHARMA INC's ticker is PLXP and the CUSIP is 72942A107. A total of 16 filers reported holding PLX PHARMA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of PLX PHARMA INC
ValueSharesWeighting
Q1 2023$37,612
-32.3%
289,094
-14.6%
0.00%
Q4 2022$55,552
-92.3%
338,522
-69.7%
0.00%
Q3 2022$726,000
-72.9%
1,115,806
+1.4%
0.00%
Q2 2022$2,675,000
-39.9%
1,100,8520.0%0.00%
Q1 2022$4,448,000
-51.4%
1,100,852
-3.7%
0.00%
Q4 2021$9,159,000
-58.5%
1,143,345
-0.1%
0.00%
-100.0%
Q3 2021$22,095,000
+69.0%
1,144,822
+20.9%
0.00%
Q2 2021$13,073,000
+59.3%
947,301
+4.3%
0.00%
Q1 2021$8,205,000
+404.6%
908,636
+208.4%
0.00%
Q4 2020$1,626,000
+70.8%
294,5950.0%0.00%
Q3 2020$952,000
-0.2%
294,5950.0%0.00%
Q2 2020$954,000
+43.9%
294,5950.0%0.00%
Q1 2020$663,000
-48.5%
294,5950.0%0.00%
Q4 2019$1,287,000
-14.3%
294,5950.0%0.00%
Q3 2019$1,502,000
+43.2%
294,595
+102.3%
0.00%
Q2 2019$1,049,000
+77.2%
145,649
+29.2%
0.00%
Q1 2019$592,000
+305.5%
112,775
+18.1%
0.00%
Q4 2018$146,000
-77.9%
95,475
-41.6%
0.00%
Q3 2018$662,000
+103.1%
163,431
+98.0%
0.00%
Q2 2018$326,000
+18.1%
82,521
+0.1%
0.00%
Q1 2018$276,000
-29.2%
82,459
+45.9%
0.00%
Q4 2017$390,000
+68.8%
56,528
+59.2%
0.00%
Q3 2017$231,00035,5010.00%
Other shareholders
PLX PHARMA INC shareholders Q3 2020
NameSharesValueWeighting ↓
Ground Swell Capital, LLC 36,407$292,0001.70%
FRIESS ASSOCIATES LLC 278,071$2,227,0000.87%
MSD Partners, L.P. 5,625,000$45,057,0000.49%
Park West Asset Management LLC 1,473,218$11,800,0000.23%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 62,673$502,0000.23%
O'Brien Greene & Co. Inc 60,340$483,0000.16%
Eidelman Virant Capital 27,000$219,0000.08%
Heritage Way Advisors, LLC 25,000$200,0000.08%
GW&K Investment Management, LLC 432,871$3,467,0000.03%
Alpine Global Management, LLC 16,380$131,0000.02%
View complete list of PLX PHARMA INC shareholders